Clinical Trial: Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Study Status: Available
Recruit Status: Available
Study Type: Expanded Access
Official Title: An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Brief Summary: Provide patients with serious AdV infection or disease access to treatment with BCV.
Detailed Summary:
Sponsor: Chimerix
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Chimerix
Dates:
Date Received: November 3, 2015
Date Started:
Date Completion:
Last Updated: December 7, 2016
Last Verified: December 2016